Please join us every Monday for the Corporate Update Call
6:30pm Pacific/9:30pm Eastern
712.338.8000, PIN 7157#
Listen to an interview with Dr. Robin L Smith on "Steve Crowley's American Scene Radio Show":
Announcing a new addition to the Ceres Living Medical Advisory Board!
We are pleased to welcome Dr. Kaare Kolstad to our team.
Dr. Kolstad is an orthopedic surgeon with a practice that focuses on the treatment of sports medicine injuries. He has extensive training involving high school, college and professional athletes in New York, Philadelphia and Houston and trained under one of the founders of the discipline of sports medicine, James Nicholas. Dr. Kolstad has many peer reviewed articles and abstracts as well as a book chapter on rehabilitation of the sports shoulder.
Dr. Kolstad was formerly the Assistant Team Physician for: the New York Jets, Hofstra University, the New York Rangers, Hunter College, the New York Islanders, Locust Valley High School in New York and the New Jersey Red Dogs. During his training Dr. Kolstad was also involved with caring for the Philadelphia Eagles and Philadelphia Phillies.
To learn more about Dr. Kolstad, visit the Medical Advisory Board link from the Product menu of this website.
![]() | Don't miss the AUSTIN |
Milestone MomentsWe're proud to recognize the following Ceres Living distributors who reached the National Director position in one week!
Carl Troutner
Chris Herriford
Sherry Martin
It's our pleasure to recognize the following Ceres Living distributors who reached the Director position in one week!
Heidi Woolard
Lori McColl
Michael Chester
Vaughn Tarver
NeoStem Featured in Business Week.doc; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey
NeoStem Obtains Exclusive License to Innovative Stem Cell Procedure Treating Musculoskeletal Diseases
NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC
NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStem's VSEL Technology and Advancement of Medical Tourism Initiatives
NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Company's Audit Committee